These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1369719)

  • 1. Role of serotonin in arteriolar thrombosis and secondary vasospasm.
    Drouet L; Bal Dit Sollier C; Ruton S; Pignaud G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S49-53. PubMed ID: 1369719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP plays a key role in thrombogenesis in rats.
    Maffrand JP; Bernat A; Delebassée D; Defreyn G; Cazenave JP; Gordon JL
    Thromb Haemost; 1988 Apr; 59(2):225-30. PubMed ID: 3133809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serotonin in thrombogenesis.
    De Clerck F
    Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial thrombosis--an experimental approach].
    Bourgain RH
    Verh K Acad Geneeskd Belg; 1989; 51(5):429-43; discussion 444. PubMed ID: 2618157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser-induced thrombus formation and vascular reactivity in the microcirculation of the spontaneously hypertensive rat.
    Görög P; Kovács IB
    Blood Vessels; 1977; 14(5):294-302. PubMed ID: 871532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbaric osteonecrosis: a consequence of intravascular bubble formation, endothelial damage, and platelet thrombosis.
    Slichter SJ; Stegall P; Smith K; Huang TW; Harker LA
    J Lab Clin Med; 1981 Oct; 98(4):568-90. PubMed ID: 7288270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion.
    Lindberg RA; Slaaf DW; Lentsch AB; Miller FN
    Microvasc Res; 1994 Mar; 47(2):203-21. PubMed ID: 7517491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo.
    Sim D; Flaumenhaft R; Furie B; Furie B
    Microcirculation; 2005; 12(3):301-11. PubMed ID: 15814438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of thrombosis and vasospasm in peripheral vascular disease.
    Hollenberg NK
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S21-8. PubMed ID: 1717769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotic reactions of vascular anastomoses: comparison of model studies with experimental findings].
    Seiffge D
    Vasa Suppl; 1991; 32():54-65. PubMed ID: 1771576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo.
    Yamashita T; Shoge M; Oda E; Yamamoto Y; Giddings JC; Kashiwagi S; Suematsu M; Yamamoto J
    Platelets; 2006 May; 17(3):201-6. PubMed ID: 16702048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serotonin on platelets and blood vessels.
    De Clerck F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S1-5. PubMed ID: 1717767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.
    Takiguchi Y; Wada K; Nakashima M
    Thromb Haemost; 1992 Oct; 68(4):460-3. PubMed ID: 1448780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.
    Schechter MD
    Life Sci; 1997; 60(6):PL83-90. PubMed ID: 9031690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.